EcoDrugPlus

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSCVAG00000007300
Gene Symbol: EZH2
3 Cross references
240 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSCVAG00000021165
Gene Symbol: EGFR
3 Cross references
212 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSCVAG00000005876
Gene Symbol: EPHX2
1 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSCVAG00000005423
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCVAG00000001270
Gene Symbol: ERBB3
3 Cross references
210 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCVAG00000016311
Gene Symbol: ERBB4
3 Cross references
222 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSCVAG00000010549
Gene Symbol: ESR1
3 Cross references
214 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSCVAG00000010717
Gene Symbol: LOC107084874
3 Cross references
207 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSCVAG00000003488
Gene Symbol: LOC107094552
3 Cross references
200 Possible Orthologues:

Estrogen Receptor-Like

Ensembl ID : ENSCVAG00000001551
Gene Symbol: LOC107081657
3 Cross references
214 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSCVAG00000012772
Gene Symbol: LOC107086944
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCVAG00000016558
Gene Symbol: XPO1
3 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).